Global Synthetic Hormones Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Synthetic Hormones Market Research Report 2024
Synthetic hormones are foreign molecules that are produced in a laboratory and used to cure hormonal imbalances in men and women. Synthetic hormones such as progesterone, estrogen, thyroid hormone, testosterone, and insulin are commonly utilized to treat a variety of medical problems. These hormones are extremely active even at low doses, and long-term usage of synthetic hormones has been related to a variety of adverse effects. Some synthetic hormones on the market include Ferring B.V.'s Zomacton injectable (Somatropin), which is used to treat growth hormone insufficiency in children.
According to Mr Accuracy reports new survey, global Synthetic Hormones market is projected to reach US$ 270.8 million in 2029, increasing from US$ 214 million in 2022, with the CAGR of 3.6% during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Synthetic Hormones market research.
The synthetic hormones market refers to the segment of the pharmaceutical industry that focuses on the development, production, and sale of synthetic or artificially produced hormones. Synthetic hormones are designed to mimic the effects of naturally occurring hormones in the body. Synthetic hormones play a crucial role in various medical treatments and therapies. They are used for a range of purposes, including hormone replacement therapy (HRT), contraception, fertility treatments, and management of hormonal disorders. Common synthetic hormones include estrogen, progesterone, testosterone, and various forms of birth control hormones. The market for synthetic hormones has witnessed significant growth in recent years due to several factors. One of the key drivers is the increasing prevalence of hormonal imbalances and disorders, such as menopause, polycystic ovary syndrome (PCOS), and hypogonadism. Additionally, the growing aging population and the increasing interest in anti-aging treatments have also contributed to the market expansion. Advancements in the field of biotechnology and pharmaceutical research have led to the development of advanced synthetic hormone formulations, including sustained-release formulations and combination therapies. These innovations offer improved efficacy, convenience, and patient compliance, further driving the market growth. The market is characterized by the presence of both generic and branded synthetic hormone products. Generic drugs are usually more affordable, leading to their widespread adoption, especially in developing regions. However, branded products continue to dominate the market in developed countries due to their brand recognition, marketing strategies, and perceived quality.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Synthetic Hormones market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Pfizer, Inc.
McGuff Pharmaceuticals, Inc.
Lyndra Therapeutics, Inc.
Ferring B. V.
Slayback Pharma
Lupin Pharmaceuticals, Inc.
Acerus Pharmaceuticals Corporation
IBSA Institut Biochimique SA
Endo International plc
American Reagent, Inc.
Merck Serono
Novo Nordisk
F. Hoffmann-La Roche
BioPartners
Eli Lilly
Segment by Type
Steroid Hormones
Peptide Hormone
Amino Acid Derivatives
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Synthetic Hormones report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source
According to Mr Accuracy reports new survey, global Synthetic Hormones market is projected to reach US$ 270.8 million in 2029, increasing from US$ 214 million in 2022, with the CAGR of 3.6% during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Synthetic Hormones market research.
The synthetic hormones market refers to the segment of the pharmaceutical industry that focuses on the development, production, and sale of synthetic or artificially produced hormones. Synthetic hormones are designed to mimic the effects of naturally occurring hormones in the body. Synthetic hormones play a crucial role in various medical treatments and therapies. They are used for a range of purposes, including hormone replacement therapy (HRT), contraception, fertility treatments, and management of hormonal disorders. Common synthetic hormones include estrogen, progesterone, testosterone, and various forms of birth control hormones. The market for synthetic hormones has witnessed significant growth in recent years due to several factors. One of the key drivers is the increasing prevalence of hormonal imbalances and disorders, such as menopause, polycystic ovary syndrome (PCOS), and hypogonadism. Additionally, the growing aging population and the increasing interest in anti-aging treatments have also contributed to the market expansion. Advancements in the field of biotechnology and pharmaceutical research have led to the development of advanced synthetic hormone formulations, including sustained-release formulations and combination therapies. These innovations offer improved efficacy, convenience, and patient compliance, further driving the market growth. The market is characterized by the presence of both generic and branded synthetic hormone products. Generic drugs are usually more affordable, leading to their widespread adoption, especially in developing regions. However, branded products continue to dominate the market in developed countries due to their brand recognition, marketing strategies, and perceived quality.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Synthetic Hormones market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Pfizer, Inc.
McGuff Pharmaceuticals, Inc.
Lyndra Therapeutics, Inc.
Ferring B. V.
Slayback Pharma
Lupin Pharmaceuticals, Inc.
Acerus Pharmaceuticals Corporation
IBSA Institut Biochimique SA
Endo International plc
American Reagent, Inc.
Merck Serono
Novo Nordisk
F. Hoffmann-La Roche
BioPartners
Eli Lilly
Segment by Type
Steroid Hormones
Peptide Hormone
Amino Acid Derivatives
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Synthetic Hormones report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices